Oral contraceptive use and the risk of inflammatory bowel disease

Epidemiology (Cambridge, Mass.), 3(4), 374-378

DOI 10.1097/00001648-199207000-00014 PMID 1637902 Source

Abstract

We used rosters of the Crohn's and Colitis Foundation of America to identify potential cases and peer-nominated controls to explore the reported association between oral contraceptives and inflammatory bowel disease. Overall, women who used oral contraceptives were at increased risk of developing Crohn's disease (odds ratio = 1.49, 95% confidence interval (CI) = 0.99-2.26). The findings persisted after adjustment for age at symptom onset, decade of onset, education, marital status, and location of disease. There was an interaction with cigarette smoking; the risk associated with oral contraceptives was elevated in current smokers (odds ratio = 2.64, 95% CI = 1.22-5.75), but not in former smokers or never-smokers. The risk was not elevated for ulcerative colitis (odds ratio = 1.10, 95% CI = 0.65-1.85).

Topics

oral contraceptive crohn disease risk, birth control pill inflammatory bowel disease, hormonal contraception ibd risk, oral contraceptive side effects ibd, contraceptive pill crohn disease association, birth control inflammatory disease risk, oral contraceptive autoimmune disease, contraceptive pill gut inflammation, hormonal contraception smoking crohn, birth control pill adverse effects

Cite this article

Sandler, R., Wurzelmann, J. I., & Lyles, C. (1992). Oral contraceptive use and the risk of inflammatory bowel disease. *Epidemiology (Cambridge, Mass.)*, *3*(4), 374-378. https://doi.org/10.1097/00001648-199207000-00014

Related articles